Does glycoprotein IIB/IIIA resistance exist?
作者信息
Smit J J J, van 't Hof A W J
机构信息
Department of Cardiology, Isala Clinics, Zwolle, the Netherlands.
出版信息
Neth Heart J. 2007;15(11):367-8. doi: 10.1007/BF03086016.
Abstract
摘要
相似文献
1
Does glycoprotein IIB/IIIA resistance exist?是否存在糖蛋白IIB/IIIA抵抗？
Neth Heart J. 2007;15(11):367-8. doi: 10.1007/BF03086016.
2
3
Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.血小板糖蛋白IIb-IIIa数量及糖蛋白IIIa Leu33Pro多态性对血小板聚集及对糖蛋白IIb-IIIa拮抗剂敏感性的影响
Platelets. 2007 Nov;18(7):506-14. doi: 10.1080/09537100701326739.
4
Dissociation of the glycoprotein IIb-IIIa complex in isolated human platelet membranes. Dependence of pH divalent cations.人离体血小板膜中糖蛋白IIb-IIIa复合物的解离。pH值和二价阳离子的依赖性。
Biochim Biophys Acta. 1982 Jul 14;689(1):21-30. doi: 10.1016/0005-2736(82)90184-5.
5
Discovery of novel antagonists of glycoprotein IIb/IIIa-mediated platelet aggregation through virtual screening.
Bioorg Med Chem Lett. 2015 Mar 15;25(6):1249-53. doi: 10.1016/j.bmcl.2015.01.053. Epub 2015 Jan 28.
6
Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.血小板糖蛋白IIb/IIIa抑制剂在急性冠状动脉综合征中的当前作用。
JAMA. 2000 Sep 27;284(12):1549-58. doi: 10.1001/jama.284.12.1549.
7
Effect of cepharanthin and cytochalasin D on platelet internalization of anti-glycoprotein IIb/IIIa antibodies.千金藤素和细胞松弛素D对抗糖蛋白IIb/IIIa抗体血小板内化作用的影响。
Autoimmunity. 1994;18(1):23-9. doi: 10.3109/08916939409014676.
8
Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials.糖蛋白IIb/IIIa受体抑制剂治疗并发颅内出血的发生率：主要临床试验的汇总分析
Am J Med. 2000 Aug 15;109(3):213-7. doi: 10.1016/s0002-9343(00)00453-8.
9
The clinical significance of circulating B cells secreting anti-glycoprotein IIb/IIIa antibody and platelet glycoprotein IIb/IIIa in patients with primary immune thrombocytopenia.原发性免疫性血小板减少症患者中分泌抗糖蛋白IIb/IIIa抗体的循环B细胞及血小板糖蛋白IIb/IIIa的临床意义
Hematology. 2012 Sep;17(5):283-90. doi: 10.1179/1607845412Y.0000000014.
10
Efficacy and safety of glycoprotein IIb/IIIa receptor antagonists for patients undergoing percutaneous coronary intervention within twelve hours of fibrinolysis.溶栓后 12 小时内行经皮冠状动脉介入治疗的患者使用糖蛋白 IIb/IIIa 受体拮抗剂的疗效和安全性。
Catheter Cardiovasc Interv. 2011 Sep 1;78(3):376-84. doi: 10.1002/ccd.22825. Epub 2011 Mar 16.
本文引用的文献
1
2
Ongoing tirofiban in myocardial infarction evaluation (On-TIME) 2 trial: rationale and study design.替罗非班在心肌梗死评估中的持续应用（On-TIME）2试验：原理与研究设计。
EuroIntervention. 2007 Nov;3(3):371-80. doi: 10.4244/eijv3i3a67.
3
Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial.替罗非班高剂量与阿昔单抗抑制 ST 段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后血小板功能：一项随机试验。
Neth Heart J. 2007;15(11):375-81. doi: 10.1007/BF03086018.
4
Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.阿司匹林对血小板功能剂量相关效应的评估：阿司匹林诱导血小板效应（ASPECT）研究结果
Circulation. 2007 Jun 26;115(25):3156-64. doi: 10.1161/CIRCULATIONAHA.106.675587. Epub 2007 Jun 11.
5
Association between level of platelet inhibition after early use of abciximab and myocardial reperfusion in ST-elevation acute myocardial Infarction treated by primary percutaneous coronary intervention.早期使用阿昔单抗后血小板抑制水平与直接经皮冠状动脉介入治疗的ST段抬高型急性心肌梗死心肌再灌注之间的关联
Am J Cardiol. 2006 Mar 15;97(6):798-803. doi: 10.1016/j.amjcard.2005.10.019. Epub 2006 Jan 18.
6
Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study.氯吡格雷对支架内血栓形成患者血小板反应性的影响：CREST研究结果
J Am Coll Cardiol. 2005 Nov 15;46(10):1827-32. doi: 10.1016/j.jacc.2005.07.056. Epub 2005 Oct 19.
7
Determinants of the interindividual variability in response to antiplatelet drugs.
J Thromb Haemost. 2005 Aug;3(8):1597-602. doi: 10.1111/j.1538-7836.2005.01380.x.
8
Variability in platelet responsiveness to clopidogrel among 544 individuals.544名个体中血小板对氯吡格雷反应性的变异性。
J Am Coll Cardiol. 2005 Jan 18;45(2):246-51. doi: 10.1016/j.jacc.2004.09.067.
9
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.在ST段抬高型心肌梗死的经皮冠状动脉介入治疗期间，不同抗血小板治疗方案后实现的血小板聚集抑制。
J Am Coll Cardiol. 2004 Sep 15;44(6):1187-93. doi: 10.1016/j.jacc.2004.06.050.
10
Platelet function predicts myocardial damage in patients with acute myocardial infarction.血小板功能可预测急性心肌梗死患者的心肌损伤。
Circulation. 2004 Sep 14;110(11):1392-7. doi: 10.1161/01.CIR.0000141575.92958.9C. Epub 2004 Aug 16.
Zotero 插件